Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lynne Cresswell is active.

Publication


Featured researches published by Lynne Cresswell.


PLOS ONE | 2012

Adverse drug reactions in children--a systematic review.

Rebecca Smyth; Elizabeth Gargon; Jamie Kirkham; Lynne Cresswell; Su Golder; Rosalind L. Smyth; Paula Williamson

Background Adverse drug reactions in children are an important public health problem. We have undertaken a systematic review of observational studies in children in three settings: causing admission to hospital, occurring during hospital stay and occurring in the community. We were particularly interested in understanding how ADRs might be better detected, assessed and avoided. Methods and Findings We searched nineteen electronic databases using a comprehensive search strategy. In total, 102 studies were included. The primary outcome was any clinical event described as an adverse drug reaction to one or more drugs. Additional information relating to the ADR was collected: associated drug classification; clinical presentation; associated risk factors; methods used for assessing causality, severity, and avoidability. Seventy one percent (72/102) of studies assessed causality, and thirty four percent (34/102) performed a severity assessment. Only nineteen studies (19%) assessed avoidability. Incidence rates for ADRs causing hospital admission ranged from 0.4% to 10.3% of all children (pooled estimate of 2.9% (2.6%, 3.1%)) and from 0.6% to 16.8% of all children exposed to a drug during hospital stay. Anti-infectives and anti-epileptics were the most frequently reported therapeutic class associated with ADRs in children admitted to hospital (17 studies; 12 studies respectively) and children in hospital (24 studies; 14 studies respectively), while anti-infectives and non-steroidal anti-inflammatory drugs (NSAIDs) were frequently reported as associated with ADRs in outpatient children (13 studies; 6 studies respectively). Fourteen studies reported rates ranging from 7%–98% of ADRs being either definitely/possibly avoidable. Conclusions There is extensive literature which investigates ADRs in children. Although these studies provide estimates of incidence in different settings and some indication of the therapeutic classes most frequently associated with ADRs, further work is needed to address how such ADRs may be prevented.


BMC Medicine | 2013

Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions

Signe Thiesen; Elizabeth J Conroy; Jennifer R Bellis; Louise E Bracken; Helena Mannix; Kim A Bird; Jennifer C Duncan; Lynne Cresswell; Jamie Kirkham; Matthew Peak; Paula Williamson; Anthony J Nunn; Mark A. Turner; Munir Pirmohamed; Rosalind L Smyth

BackgroundAdverse drug reactions (ADRs) are an important cause of harm in children. Current data are incomplete due to methodological differences between studies: only half of all studies provide drug data, incidence rates vary (0.6% to 16.8%) and very few studies provide data on causality, severity and risk factors of pediatric ADRs. We aimed to determine the incidence of ADRs in hospitalized children, to characterize these ADRs in terms of type, drug etiology, causality and severity and to identify risk factors.MethodsWe undertook a year-long, prospective observational cohort study of admissions to a single UK pediatric medical and surgical secondary and tertiary referral center (Alder Hey, Liverpool, UK). Children between 0 and 16 years 11 months old and admitted for more than 48 hours were included. Observed outcomes were occurrence of ADR and time to first ADR for the risk factor analysis.ResultsA total of 5,118 children (6,601 admissions) were included, 17.7% of whom experienced at least one ADR. Opiate analgesics and drugs used in general anesthesia (GA) accounted for more than 50% of all drugs implicated in ADRs. Of these ADRs, 0.9% caused permanent harm or required admission to a higher level of care. Children who underwent GA were at more than six times the risk of developing an ADR than children without a GA (hazard ratio (HR) 6.40; 95% confidence interval (CI) 5.30 to 7.70). Other factors increasing the risk of an ADR were increasing age (HR 1.06 for each year; 95% CI 1.04 to 1.07), increasing number of drugs (HR 1.25 for each additional drug; 95% CI 1.22 to 1.28) and oncological treatment (HR 1.90; 95% CI 1.40 to 2.60).ConclusionsADRs are common in hospitalized children and children who had undergone a GA had more than six times the risk of developing an ADR. GA agents and opiate analgesics are a significant cause of ADRs and have been underrepresented in previous studies. This is a concern in view of the increasing number of pediatric short-stay surgeries.


Statistics in Medicine | 2011

Assessment of joint symmetry in arthritis.

Lynne Cresswell; Vern Farewell

We evaluate three methods for the assessment of symmetry in the joints affected by an arthritic disease. The first two methods, based on published methodology, are limited by their assumptions. We introduce a third method that enables a more comprehensive investigation. In common with previous methods, this method examines tabulations of observed data for evidence of symmetry. Expected values for the table cells are simulated under an assumption of independent joint disease, whilst allowing for differences between patients, and joint locations, in terms of their susceptibility to disease symptoms. Departures of observed from expected values are assessed via a Pearson-type goodness-of-fit test and are examined for consistency with symmetry. We illustrate the three methods using data on the damage accrued in the hand joints of patients registered at the University of Toronto Psoriatic Arthritis clinic.


Cochrane Database of Systematic Reviews | 2011

Comparison of protocols and registry entries to published reports for randomised controlled trials

Kerry Dwan; Douglas G. Altman; Lynne Cresswell; Michaela Blundell; Carrol Gamble; Paula Williamson


Archive | 2014

Causality assessment of adverse drug reactions

Rosalind L. Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed


Programme Grants for Applied Research , 2 (3) (2014) | 2014

ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods

Rosalind L Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed


Archive | 2014

Systematic review of paediatric adverse drug reactions

Rosalind L Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed


Archive | 2014

Research Implications from Adverse Drug Reactions In Children

Rosalind L Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed


Archive | 2014

Development of the Liverpool Adverse Drug Reaction Avoidability Tool

Rosalind L Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed


Archive | 2014

Developing a communication strategy about suspected adverse drug reactions affecting children

Rosalind L Smyth; Matthew Peak; Mark A. Turner; Anthony J Nunn; Paula Williamson; Bridget Young; Janine Arnott; Jennifer R Bellis; Kim A Bird; Louise E Bracken; Elizabeth J Conroy; Lynne Cresswell; Jennifer C Duncan; Ruairi M Gallagher; Elizabeth Gargon; Hannah Hesselgreaves; Jamie Kirkham; Helena Mannix; Rebecca Md Smyth; Signe Thiesen; Munir Pirmohamed

Collaboration


Dive into the Lynne Cresswell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matthew Peak

University of Central Lancashire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge